XTL Biopharmaceuticals Ltd.
XTLB
$1.33
-$0.03-2.21%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/7/2025
-
TipRanks Financial Blog
4/7/2025
-
The Fly
4/7/2025
-
Globe Newswire
12/31/2024
-
TipRanks Financial Blog
12/31/2024
-
TipRanks Financial Blog
11/19/2024
-
TipRanks Financial Blog
11/12/2024
-
TipRanks Financial Blog
8/14/2024
-
TipRanks Financial Blog
8/14/2024
-
The Fly
8/14/2024
-
Globe Newswire
7/22/2024
-
TipRanks Financial Blog
6/17/2024
-
InvestorPlace
6/5/2024
-
TipRanks Financial Blog
6/5/2024
-
The Fly
6/5/2024
-
Globe Newswire
5/13/2024
-
InvestorPlace
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, April 30, 2024
Period Date
Sunday, December 31, 2023
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 611 6600
Address
26 Ben-Gurion St.
Ramat Gan, 5112001
Ramat Gan, 5112001
Country
Year Founded
Business Description
Sector
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug...
more